1 Market Overview of Parasitic Diseases Therapeutic 1.1 Parasitic Diseases Therapeutic Market Overview 1.1.1 Parasitic Diseases Therapeutic Product Scope 1.1.2 Market Status and Outlook 1.2 Global Parasitic Diseases Therapeutic Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Parasitic Diseases Therapeutic Market Size by Region (2015-2026) 1.4 Global Parasitic Diseases Therapeutic Historic Market Size by Region (2015-2020) 1.5 Global Parasitic Diseases Therapeutic Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Parasitic Diseases Therapeutic Market Size YoY Growth (2015-2026) 1.6.1 North America Parasitic Diseases Therapeutic Market Size YoY Growth (2015-2026) 1.6.2 Europe Parasitic Diseases Therapeutic Market Size YoY Growth (2015-2026) 1.6.3 China Parasitic Diseases Therapeutic Market Size YoY Growth (2015-2026) 1.6.4 Rest of Asia Pacific Parasitic Diseases Therapeutic Market Size YoY Growth (2015-2026) 1.6.5 Latin America Parasitic Diseases Therapeutic Market Size YoY Growth (2015-2026) 1.6.6 Middle East & Africa Parasitic Diseases Therapeutic Market Size YoY Growth (2015-2026) 2 Parasitic Diseases Therapeutic Market Overview by Type 2.1 Global Parasitic Diseases Therapeutic Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Parasitic Diseases Therapeutic Historic Market Size by Type (2015-2020) 2.3 Global Parasitic Diseases Therapeutic Forecasted Market Size by Type (2021-2026) 2.4 Peptides Medicine 2.5 Insect Repellent 2.6 Acaricide 2.7 Other 3 Parasitic Diseases Therapeutic Market Overview by Application 3.1 Global Parasitic Diseases Therapeutic Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Parasitic Diseases Therapeutic Historic Market Size by Application (2015-2020) 3.3 Global Parasitic Diseases Therapeutic Forecasted Market Size by Application (2021-2026) 3.4 Commercial 3.5 Household 4 Global Parasitic Diseases Therapeutic Competition Analysis by Players 4.1 Global Parasitic Diseases Therapeutic Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parasitic Diseases Therapeutic as of 2019) 4.3 Date of Key Manufacturers Enter into Parasitic Diseases Therapeutic Market 4.4 Global Top Players Parasitic Diseases Therapeutic Headquarters and Area Served 4.5 Key Players Parasitic Diseases Therapeutic Product Solution and Service 4.6 Competitive Status 4.6.1 Parasitic Diseases Therapeutic Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Bayer 5.1.1 Bayer Profile 5.1.2 Bayer Main Business and Company’s Total Revenue 5.1.3 Bayer Products, Services and Solutions 5.1.4 Bayer Revenue (US$ Million) (2015-2020) 5.1.5 Bayer Recent Development and Reaction to Covid-19 5.2 F. Hoffmann-La Roche 5.2.1 F. Hoffmann-La Roche Profile 5.2.2 F. Hoffmann-La Roche Main Business and Company’s Total Revenue 5.2.3 F. Hoffmann-La Roche Products, Services and Solutions 5.2.4 F. Hoffmann-La Roche Revenue (US$ Million) (2015-2020) 5.2.5 F. Hoffmann-La Roche Recent Development and Reaction to Covid-19 5.3 GlaxoSmithKline 5.5.1 GlaxoSmithKline Profile 5.3.2 GlaxoSmithKline Main Business and Company’s Total Revenue 5.3.3 GlaxoSmithKline Products, Services and Solutions 5.3.4 GlaxoSmithKline Revenue (US$ Million) (2015-2020) 5.3.5 Pfizer Recent Development and Reaction to Covid-19 5.4 Pfizer 5.4.1 Pfizer Profile 5.4.2 Pfizer Main Business and Company’s Total Revenue 5.4.3 Pfizer Products, Services and Solutions 5.4.4 Pfizer Revenue (US$ Million) (2015-2020) 5.4.5 Pfizer Recent Development and Reaction to Covid-19 5.5 Sanaria 5.5.1 Sanaria Profile 5.5.2 Sanaria Main Business and Company’s Total Revenue 5.5.3 Sanaria Products, Services and Solutions 5.5.4 Sanaria Revenue (US$ Million) (2015-2020) 5.5.5 Sanaria Recent Development and Reaction to Covid-19 ... 6 North America Parasitic Diseases Therapeutic by Players and by Application 6.1 North America Parasitic Diseases Therapeutic Market Size and Market Share by Players (2015-2020) 6.2 North America Parasitic Diseases Therapeutic Market Size by Application (2015-2020) 7 Europe Parasitic Diseases Therapeutic by Players and by Application 7.1 Europe Parasitic Diseases Therapeutic Market Size and Market Share by Players (2015-2020) 7.2 Europe Parasitic Diseases Therapeutic Market Size by Application (2015-2020) 8 China Parasitic Diseases Therapeutic by Players and by Application 8.1 China Parasitic Diseases Therapeutic Market Size and Market Share by Players (2015-2020) 8.2 China Parasitic Diseases Therapeutic Market Size by Application (2015-2020) 9 Rest of Asia Pacific Parasitic Diseases Therapeutic by Players and by Application 9.1 Rest of Asia Pacific Parasitic Diseases Therapeutic Market Size and Market Share by Players (2015-2020) 9.2 Rest of Asia Pacific Parasitic Diseases Therapeutic Market Size by Application (2015-2020) 10 Latin America Parasitic Diseases Therapeutic by Players and by Application 10.1 Latin America Parasitic Diseases Therapeutic Market Size and Market Share by Players (2015-2020) 10.2 Latin America Parasitic Diseases Therapeutic Market Size by Application (2015-2020) 11 Middle East & Africa Parasitic Diseases Therapeutic by Players and by Application 11.1 Middle East & Africa Parasitic Diseases Therapeutic Market Size and Market Share by Players (2015-2020) 11.2 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Application (2015-2020) 12 Parasitic Diseases Therapeutic Market Dynamics 12.1 Covid-19 Impact: Industry Trends 12.2 Covid-19 Impact: Market Drivers 12.3 Covid-19 Impact: Market Challenges 12.4 Porter’s Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables Table 1. Global Market Parasitic Diseases Therapeutic Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Parasitic Diseases Therapeutic Market Size by Region (2015-2020) (US$ Million) Table 3. Global Parasitic Diseases Therapeutic Market Size Share by Region (2015-2020) Table 4. Global Parasitic Diseases Therapeutic Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Parasitic Diseases Therapeutic Forecasted Market Size Share by Region (2021-2026) Table 6. Global Parasitic Diseases Therapeutic Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Parasitic Diseases Therapeutic Market Size by Type (2015-2020) (US$ Million) Table 8. Global Parasitic Diseases Therapeutic Revenue Market Share by Type (2015-2020) Table 9. Global Parasitic Diseases Therapeutic Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Parasitic Diseases Therapeutic Revenue Market Share by Type (2021-2026) Table 11. Global Parasitic Diseases Therapeutic Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Parasitic Diseases Therapeutic Market Size by Application (2015-2020) (US$ Million) Table 13. Global Parasitic Diseases Therapeutic Revenue Market Share by Application (2015-2020) Table 14. Global Parasitic Diseases Therapeutic Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Parasitic Diseases Therapeutic Revenue Market Share by Application (2021-2026) Table 16. Global Parasitic Diseases Therapeutic Revenue (US$ Million) by Players (2015-2020) Table 17. Global Parasitic Diseases Therapeutic Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parasitic Diseases Therapeutic as of 2019) Table 19. Date of Key Manufacturers Enter into Parasitic Diseases Therapeutic Market Table 20. Global Parasitic Diseases Therapeutic Top Players Headquarters and Area Served Table 21. Parasitic Diseases Therapeutic Product Solution and Service Table 22. Global Parasitic Diseases Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Bayer Basic Information List Table 25. Bayer Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 Table 26. Bayer Parasitic Diseases Therapeutic Products, Services and Solutions Table 27. Revenue (Million US$) in Parasitic Diseases Therapeutic Business of Bayer (2015-2020) Table 28. Bayer Recent Developments Table 29. F. Hoffmann-La Roche Basic Information List Table 30. F. Hoffmann-La Roche Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 Table 31. F. Hoffmann-La Roche Parasitic Diseases Therapeutic Products, Services and Solutions Table 32. Revenue (Million US$) in Parasitic Diseases Therapeutic Business of F. Hoffmann-La Roche (2015-2020) Table 33. F. Hoffmann-La Roche Recent Developments Table 34. GlaxoSmithKline Basic Information List Table 35. GlaxoSmithKline Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 Table 36. GlaxoSmithKline Parasitic Diseases Therapeutic Products, Services and Solutions Table 37. Revenue (Million US$) in Parasitic Diseases Therapeutic Business of GlaxoSmithKline (2015-2020) Table 38. GlaxoSmithKline Recent Developments Table 39. Pfizer Basic Information List Table 40. Pfizer Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 Table 41. Pfizer Parasitic Diseases Therapeutic Products, Services and Solutions Table 42. Revenue (Million US$) in Parasitic Diseases Therapeutic Business of Pfizer (2015-2020) Table 43. Pfizer Recent Developments Table 44. Sanaria Basic Information List Table 45. Sanaria Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 Table 46. Sanaria Parasitic Diseases Therapeutic Products, Services and Solutions Table 47. Revenue (Million US$) in Parasitic Diseases Therapeutic Business of Sanaria (2015-2020) Table 48. Sanaria Recent Developments Table 49. Global Parasitic Diseases Therapeutic Market Size by Type (2015-2020) (Million US$) Table 50. North America Parasitic Diseases Therapeutic Market Size by Players (2015-2020) (US$ Million) Table 51. North America Parasitic Diseases Therapeutic Market Size Share by Players (2015-2020) Table 52. North America Parasitic Diseases Therapeutic Market Size by Application (2015-2020) (US$ Million) Table 53. Europe Parasitic Diseases Therapeutic Market Size by Players (2015-2020) (US$ Million) Table 54. Europe Parasitic Diseases Therapeutic Market Size Share by Players (2015-2020) Table 55. Europe Parasitic Diseases Therapeutic Market Size by Application (2015-2020) (US$ Million) Table 56. China Parasitic Diseases Therapeutic Market Size by Players (2015-2020) (US$ Million) Table 57. China Parasitic Diseases Therapeutic Market Size Share by Players (2015-2020) (US$ Million) Table 58. China Parasitic Diseases Therapeutic Market Size by Application (2015-2020) (US$ Million) Table 59. Rest of Asia Pacific Parasitic Diseases Therapeutic Market Size by Players (2015-2020) (US$ Million) Table 60. Rest of Asia Pacific Parasitic Diseases Therapeutic Market Size Share by Players (2015-2020) (US$ Million) Table 61. Rest of Asia Pacific Parasitic Diseases Therapeutic Market Size by Application (2015-2020) (US$ Million) Table 62. Latin America Parasitic Diseases Therapeutic Market Size by Players (2015-2020) (US$ Million) Table 63. Latin America Parasitic Diseases Therapeutic Market Size Share by Players (2015-2020) (US$ Million) Table 64. Latin America Parasitic Diseases Therapeutic Market Size by Application (2015-2020) (US$ Million) Table 65. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Players (2015-2020) (US$ Million) Table 66. Middle East & Africa Parasitic Diseases Therapeutic Market Size Share by Players (2015-2020) (US$ Million) Table 67. Middle East & Africa Parasitic Diseases Therapeutic Market Size by Application (2015-2020) (US$ Million) Table 68. Market Top Trends Table 69. Key Drivers: Impact Analysis (2021-2026) Table 70. Key Challenges Table 71. Research Programs/Design for This Report Table 72. Key Data Information from Secondary Sources Table 73. Key Data Information from Primary Sources List of Figures Figure 1. Global Parasitic Diseases Therapeutic Market Size (US$ Million) Status and Outlook (2015-2026) Figure 2. Global Parasitic Diseases Therapeutic Market Share by Regions: 2020 VS 2026 Figure 3. North America Parasitic Diseases Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 4. Europe Parasitic Diseases Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 5. China Parasitic Diseases Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Rest of Asia Pacific Parasitic Diseases Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Parasitic Diseases Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Parasitic Diseases Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Parasitic Diseases Therapeutic Market Share by Type in 2020 & 2026 Figure 10. Peptides Medicine Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Insect Repellent Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Acaricide Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Other Market Size (US$ Million) YoY Growth (2015-2026) Figure 14. Global Parasitic Diseases Therapeutic Market Size Share by Application in 2020 & 2026 Figure 15. Parasitic Diseases Therapeutic Market Size (US$ Million) and Growth Rate in Commercial (2015-2020) Figure 16. Parasitic Diseases Therapeutic Market Size (US$ Million) and Growth Rate in Household (2015-2020) Figure 17. Parasitic Diseases Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Top 5 and Top 10 Players Parasitic Diseases Therapeutic Market Share in 2019 Figure 19. Europe Parasitic Diseases Therapeutic Revenue Market Share by Application (2015-2020) Figure 20. China Parasitic Diseases Therapeutic Revenue Market Share by Application (2015-2020) Figure 21. Rest of Asia Pacific Parasitic Diseases Therapeutic Revenue Market Share by Application (2015-2020) Figure 22. Latin America Parasitic Diseases Therapeutic Revenue Market Share by Application (2015-2020) Figure 23. Middle East & Africa Parasitic Diseases Therapeutic Revenue Market Share by Application (2015-2020) Figure 24. Porter's Five Forces Analysis Figure 25. Bottom-up and Top-down Approaches for This Report Figure 26. Data Triangulation

Bayer F. Hoffmann-La Roche GlaxoSmithKline Pfizer Sanaria